MCL
Clinical trials for MCL explained in plain language.
Never miss a new study
Get alerted when new MCL trials appear
Sign up with your email to follow new studies for MCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy offers hope for aggressive lymphoma patients
Disease control Recruiting nowThis study tests a combination of two drugs, glofitamab and lenalidomide, in 43 adults with a type of blood cancer called mantle cell lymphoma that has returned or not responded to treatment, especially after a BTK inhibitor stopped working. Participants receive glofitamab throug…
Matched conditions: MCL
Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated May 26, 2026 06:24 UTC
-
New hope for High-Risk MCL: targeted therapy combo shows promise
Disease control Recruiting nowThis study tests whether giving the drug glofitamab after an initial treatment with BTKi and rituximab can better control high-risk mantle cell lymphoma (MCL) in people who have not been treated before. About 30 adults with newly diagnosed, high-risk MCL will receive this two-ste…
Matched conditions: MCL
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:23 UTC